QUINLAN PAUL T (General Counsel and Secretary) sold 2.3% of their position (733.00 shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $51.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0000907654-26-000060
Officer· General Counsel and Secretary
Since Aug 2024
-733.00
Net shares
Net seller
$51.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
733.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−733.00
Price / share
$69.69
Trade value
$51.08K
% of position
2.3%
6/15/2026
31.77K→31.03K
Total
Net shares
−733.00
Net value
-$51.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | S · Sale | −733.00 | $69.69 | $51.08K | 2.3% | 31.77K | 31.03K |
| Total | −733.00 | -$51.08K | ||||||
Derivative Transactions0
No derivative transactions reported